Search results
Results from the WOW.Com Content Network
Unilab, Inc., commonly known as Unilab (stylized in all caps), is a Philippine pharmaceutical company headquartered in Mandaluyong, Metro Manila. [1] It specializes in a wide range of consumer healthcare products such as prescription and over-the counter medications, vitamins and food supplements, and biotechnology.
In 1988 Sterling Winthrop was acquired by Eastman Kodak which sold the worldwide over the counter drug business to SmithKline Beecham in 1994. [16] Two weeks later, SmithKline Beecham sold the over-the-counter medication business in the United States, Canada and Puerto Rico to Bayer for US$1 billion. [ 17 ]
The term over-the-counter (OTC) refers to a medication that can be purchased without a medical prescription. [3] In contrast, prescription drugs require a prescription from a doctor or other health care professional and should only be used by the prescribed individual. [4]
The medication will be sold under the brand name Journavx for $15.50 per pill, according to Vertex Pharmaceuticals, the company that developed the new drug. The FDA's sign-off on the medication ...
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids, which are often available as generics for $1 or less.
DLI changed its name to The Generics Pharmacy (TGP) when it became open for franchising. [6] By 2014, The Generics Pharmacy has changed its official name to TGP with its owners believing it would promote better brand recall. [5] By 2016, the Robinsons Retail of the Gokongwei family have acquired 51 percent stake in TGP, or a majority stake. [3]
“Brand-name products are most popular in the beverage aisle, with around 68% choosing brand names over store brand alternatives — even at a higher price point,” note Balagtas and Bryant.
Solpadeine is the brand name of a range of analgesic medication containing various amounts of paracetamol, ibuprofen, caffeine and codeine, made by Omega Pharma. [1] The range was previously made by GlaxoSmithKline , which sold its portfolio of over-the-counter drugs to Omega Pharma in 2012.